Details of the Drug Reposition

General Information of This Drug (ID: DMKWGS1)

Drug Name
PBT-2   DMKWGS1
Synonyms AD/HD therapy, Prana; Alzheimers/Huntingtons disease therapy (chelating agent), Prana
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Huntington disease DISQPLA4 8A01.10 Phase 2 [1]
Alzheimer disease DISF8S70 8A20 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT01590888) Effect of PBT2 in Patients With Early to Mid Stage Huntington Disease. U.S. National Institutes of Health.